Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers
2021 · Nature Communications · 128 citations
https://doi.org/10.1038/s41467-021-26600-5
Q
Qinglan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
1.1K
Citations
18
h-index
25
i10-index
Qinglan Li is an academic researcher from Guangdong University of Technology. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Protein Degradation and Inhibitors & Epigenetics and DNA Methylation. The author has an h-index of 18, co-authored 76 publications.
ORCID: 0000-0003-0160-8774Papers by this author
worksThe hyper-activation of transcriptional enhancers in breast cancer
2019 · Clinical Epigenetics · 79 citations
https://doi.org/10.1186/s13148-019-0645-x
Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity
2024 · Nature Communications · 28 citations
https://doi.org/10.1038/s41467-024-45939-z
Single-cell multiomics reveals ENL mutation perturbs kidney developmental trajectory by rewiring gene regulatory landscape
2024 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-024-50171-w
Additional file 2: of The hyper-activation of transcriptional enhancers in breast cancer
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7842542
Supplementary tables S1-S38 from Condensate-Promoting ENL Mutation Drives Tumorigenesis <i>In Vivo</i> Through Dynamic Regulation of Histone Modifications and Gene Expression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26466814
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat